Hbk Sorce Advisory LLC I Mab Transaction History
Hbk Sorce Advisory LLC
- $2.53 Billion
- Q1 2025
A detailed history of Hbk Sorce Advisory LLC transactions in I Mab stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 46,060 shares of IMAB stock, worth $38,690. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,060Holding current value
$38,690% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMAB
# of Institutions
36Shares Held
16.9MCall Options Held
0Put Options Held
14.5K-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$5.02 Million0.19% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$3.5 Million3.04% of portfolio
-
Morgan Stanley New York, NY3.54MShares$2.98 Million0.0% of portfolio
-
Sg Americas Securities, LLC822KShares$690,5140.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny431KShares$361,8720.0% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $69.8M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...